GlassScriptPhysician profile
Thomas Caudill Githens
NPI 1841636917
$2,618.75
in general payments reported to CMS, 2019-2025
9 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $172 · 2021: $177 · 2022: $252 · 2023: $455 · 2024: $255 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $788.09 | 2019-2025 | Va-Lcp, Tfn-Advance, Lcp |
| Kls-Martin L.P. | $716.40 | 2022-2025 | |
| Stryker Corporation | $579.31 | 2019-2025 | Allograft Bio-Implants, Pangea, T2 Alpha |
| Globus Medical, INC. | $197.63 | 2023-2025 | Anthem, Arbor, Cable |
| Smith+Nephew, INC. | $177.65 | 2019-2020 | |
| Medical Device Business Services, INC. | $70.39 | 2019 | |
| Bioventus LLC | $44.92 | 2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $28.68 | 2024 | Puraply Am |
| Ucb, INC. | $15.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Githens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.